Categories
News

Dr. Agarwals Healthcare IPO: Key Details for Investors

Dr. Agarwals Healthcare’s IPO opens today, offering shares between Rs 382 and Rs 402.

Dr. Agarwals Healthcare IPO Opens for Subscription Today

Dr. Agarwals Healthcare’s initial public offering (IPO) opens for subscription today, January 29, and will close on January 31. The price band for the issue is set between Rs 382 and Rs 402 per share. This mainboard IPO is generating considerable interest, with details emerging about its grey market premium, structure, and anchor investors.  

Grey Market Premium Suggests Positive Listing:

The shares are currently trading at a premium of Rs 12 in the grey market. This indicates a potential listing price of Rs 414 per share. This represents a 2.99% increase over the upper price band of Rs 402. However, it’s crucial to remember that grey market premiums are not a guarantee of listing performance. They can fluctuate based on market sentiment.  

IPO Details: Size and Structure:

The total issue size is substantial, amounting to Rs 3,027.26 crores. This comprises a fresh issue of 0.75 crore shares, raising Rs 300 crores for the company, and an offer for sale (OFS) of 6.78 crore shares worth Rs 2,727.26 crores by existing shareholders.  

Price Band, Lot Size, and Investment:

The price band is fixed between Rs 382 and Rs 402 per share. Retail investors can bid for a minimum of 35 shares. This requires an investment of Rs 14,070 at the upper price band. For small non-institutional investors (sNIIs), the minimum application size is 15 lots (525 shares), totaling Rs 2,11,050. Large non-institutional investors (bNIIs) need to bid for a minimum of 72 lots (2,520 shares), amounting to Rs 10,13,040.  

Allotment and Listing Timeline:

The subscription period runs from January 29 to January 31. The allotment of shares is expected on February 3. Shares are tentatively listed on February 5 on both the BSE and NSE.  

Strong Anchor Investor Participation:

Dr. Agarwals Healthcare has already garnered significant interest from anchor investors, raising Rs 875.50 crores on January 28. Shares were allotted at the upper price band of Rs 402 per share to prominent domestic and foreign investors. These include the Government of Singapore and the Monetary Authority of Singapore. It also includes Invesco India Midcap Fund, Fidelity, and Goldman Sachs (Singapore) PTE. Other investors are Tiger Pacific Master Fund, Malabar India, LIC Mutual Fund, Tata MF, and Aditya Birla Life, among others.  

Key Players Managing the IPO:

Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors are leading the book-running role. They are responsible for managing the IPO. Kfin Technologies is the registrar for the issue.  

The strong anchor participation and healthy grey market premium suggest a positive outlook for the Dr. Agarwals Healthcare IPO. However, investors should conduct their own due diligence and consider market conditions before making any investment decisions.

Leave a Reply